Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    24412048 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Biological: ProSavin
2 Active, not recruiting Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: ProSavin

Indicates status has not been verified in more than two years